| ID | 800 |
|---|---|
| Name | Neuraminidase |
| Synonyms | Acetylneuraminyl hydrolase; Exo alpha sialidase; G9 sialidase; Lysosomal sialidase; N acetyl alpha neuraminidase 1; NANH; NEU; NEU 1… |
| ID | 730 |
|---|---|
| Name | OCH |
| CAS | 2,3,4,4,5,5,6,6-octachloro-2-cyclohexen-1-one |
| PubMed | Abstract | RScore(About this table) |
|---|---|---|
| 16408704 | Uhnoo I, Linde A: [Antiviral agents in influenza--current recommendations. Lakartidningen. 2005 Dec 5-11;102(49):3802-3 Anti-influenza agents are not a substitution for but a complement to vaccination]. This article summarizes a Swedish consensus guidance document on the use of antiviral drugs in the management of influenza. Vaccination remains the cornerstone for influenza prophylaxis. Treatment with neuraminidase inhibitors is recommended for high-risk groups and individuals hospitalised with influenza. Chemoprophylaxis is targeted at high-risk groups and should be considered on a case by case basis depending on the circumstances. Unvaccinated at-risk patients or seasonal vaccine strain mismatch were identified as potential indications for antiviral prophylaxis. Oseltamivir prophylaxis can otherwise be considered for influenza in a household including an at-risk individual and in outbreaks in hospitals and nursing homes. The use of antivirals in a pandemic situation is also discussed. |
1(0,0,0,1) |